Protagonist Therapeutics PTGX
NASDAQ PTGX
$140.06 +0.87 (+0.63%)
At close: Oct 2, 2026 · 4:00 PM EDT

Protagonist Therapeutics (PTGX) Interest & Investment Income (2015 - 2026)

Updated

Protagonist Therapeutics (PTGX) reported Interest & Investment Income of $6.43 million for Q2 2026, down 13.2% from $7.41 million a year earlier but up 9.4% from the prior quarter.

Analysis

Protagonist Therapeutics (PTGX) Interest & Investment Income (2015 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Protagonist Therapeutics' Interest & Investment Income came in at $26.12 million, down 11.5% year-over-year; for FY2025, it came in at $28.79 million, up 9.4% from FY2024.

  • Interest & Investment Income has increased for four consecutive years, with a five-year compound annual growth rate of 100.0% (FY2020 to FY2025).
  • By year, Interest & Investment Income came in at $26.32 million in FY2024 (+76.6%), $14.9 million in FY2023 (+266.9%), $4.06 million in FY2022 (+816.5%) and $443,000 in FY2021 (-50.8%).
  • Five-year quarterly Interest & Investment Income spans a low of $122,000 in Q3 2021 and a high of $7.68 million in Q3 2024.
  • Year over year, Interest & Investment Income has now declined in each of the last four quarters, with growth averaging 21.3% over the last eight quarters.
  • The high point for year-over-year Interest & Investment Income in five years was Q3 2022 (growth of 848.4%); the low point was Q1 2026 (a decline of 22.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $5.88 million (Q1 2026), $6.76 million (Q4 2025) and $7.05 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Protagonist Therapeutics 9.06 Bn 9.06 Bn - 6.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.43 Mn
Mar 31, 2026 5.88 Mn
Dec 31, 2025 6.76 Mn
Sep 30, 2025 7.05 Mn
Jun 30, 2025 7.41 Mn
Mar 31, 2025 7.57 Mn
Dec 31, 2024 6.85 Mn
Sep 30, 2024 7.68 Mn
Jun 30, 2024 7.40 Mn
Mar 31, 2024 4.38 Mn
Dec 31, 2023 4.24 Mn
Sep 30, 2023 4.25 Mn
Jun 30, 2023 3.91 Mn
Mar 31, 2023 2.49 Mn
Dec 31, 2022 2.25 Mn
Sep 30, 2022 1.16 Mn
Jun 30, 2022 484,000.00
Mar 31, 2022 168,000.00
Dec 31, 2021 122,000.00
Sep 30, 2021 122,000.00
API Access

Protagonist Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=PTGX&period=max&api_key=YOUR_API_KEY